Cargando…

Phase I Studies of Acebilustat: Biomarker Response and Safety in Patients with Cystic Fibrosis

There is a significant unmet need for safe and effective anti‐inflammatory treatment for cystic fibrosis. The aim of this study was to evaluate the safety of acebilustat, a leukotriene A4 hydrolase inhibitor, and its effect on inflammation biomarkers in patients with cystic fibrosis. Seventeen patie...

Descripción completa

Detalles Bibliográficos
Autores principales:	Elborn, JS, Horsley, A, MacGregor, G, Bilton, D, Grosswald, R, Ahuja, S, Springman, EB
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2016
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5351012/ https://www.ncbi.nlm.nih.gov/pubmed/27806191 http://dx.doi.org/10.1111/cts.12428

Ejemplares similares

Phase I Studies of Acebilustat: Pharmacokinetics, Pharmacodynamics, Food Effect, and CYP3A Induction
por: Elborn, JS, et al.
Publicado: (2016)

Protein biomarkers in cystic fibrosis research: where next?
por: Pattison, Sally H, et al.
Publicado: (2010)

Ciprofloxacin dry powder inhaler in cystic fibrosis
por: Elborn, J Stuart
Publicado: (2016)

Modulator treatment for people with cystic fibrosis: moving in the right direction
por: Elborn, J. Stuart
Publicado: (2020)

Book review: Hodson and Geddes’ Cystic Fibrosis
por: Horsley, Alex
Publicado: (2016)

Ivacaftor: Five‐year outcomes in the West of Scotland cystic fibrosis population
por: Al‐Din, Yasmin, et al.
Publicado: (2023)

Digital healthcare in cystic fibrosis. Learning from the pandemic to innovate future care (Commentary)()
por: Elborn, J Stuart
Publicado: (2021)

The fungal airway microbiome in cystic fibrosis and non-cystic fibrosis bronchiectasis
por: Cuthbertson, Leah, et al.
Publicado: (2021)

Hyperglycemia and Death in Cystic Fibrosis–Related Diabetes
por: Adler, Amanda I., et al.
Publicado: (2011)

Targeted therapies to improve CFTR function in cystic fibrosis
por: Brodlie, Malcolm, et al.
Publicado: (2015)

Organisms isolated from adults with Cystic Fibrosis
por: McManus, Terence E, et al.
Publicado: (2004)

International Committee on Mental Health in Cystic Fibrosis: Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus statements for screening and treating depression and anxiety
por: Quittner, Alexandra L, et al.
Publicado: (2016)

The Effect of CFTR Modulators on Airway Infection in Cystic Fibrosis
por: Harvey, Caitlyn, et al.
Publicado: (2022)

T Helper Cell Subsets Specific for Pseudomonas aeruginosa in Healthy Individuals and Patients with Cystic Fibrosis
por: Bayes, Hannah K., et al.
Publicado: (2014)

Aspergillosis and the role of mucins in cystic fibrosis
por: Cowley, Abigail C., et al.
Publicado: (2016)

Diabetes as a Determinant of Mortality in Cystic Fibrosis
por: Chamnan, Parinya, et al.
Publicado: (2010)

Eradication of Pseudomonas aeruginosa in adults with cystic fibrosis
por: Kenny, S L, et al.
Publicado: (2014)

Mediation of the total effect of cystic fibrosis‐related diabetes on mortality: A UK Cystic Fibrosis Registry cohort study
por: Tanner, Kamaryn T., et al.
Publicado: (2022)

Testing Two Different Doses of Tiotropium Respimat® in Cystic Fibrosis: Phase 2 Randomized Trial Results
por: Bradley, Judy M., et al.
Publicado: (2014)

Metabolic and respiratory consequences of a glucose load in a hypoxic patient with cystic fibrosis.
por: Elborn, J. S., et al.
Publicado: (1992)

Discordance between clinical, physiological, and radiological measures in cystic fibrosis
por: Barry, Peter J, et al.
Publicado: (2014)

Data Resource Profile: The UK Cystic Fibrosis Registry
por: Taylor-Robinson, David, et al.
Publicado: (2018)

The changing demography of the cystic fibrosis population: forecasting future numbers of adults in the UK
por: Keogh, Ruth H., et al.
Publicado: (2020)

P177 Characterisation of pathogens causing lung infection in people with cystic fibrosis by surface-enhanced Raman spectroscopy (SERS)
por: Allen, D., et al.
Publicado: (2019)

Future therapies for cystic fibrosis
por: Allen, Lucy, et al.
Publicado: (2023)

ePS5.02 Effect of omalizumab on glucocorticoid use and lung function in the treatment of allergic bronchopulmonary aspergillosis in people with cystic fibrosis: a systematic review and meta-analysis
por: Elborn, J.S., et al.
Publicado: (2022)

US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis
por: Floto, R Andres, et al.
Publicado: (2016)

1078. Expectations and Attitudes Toward Antimicrobial Stewardship Among Cystic Fibrosis Care Providers
por: Bullington, Wendy, et al.
Publicado: (2019)

STAPHYLOCOCCUS AUREUS ENTEROTOXINS IN PEOPLE WITH CYSTIC FIBROSIS (CF)
por: Wen, Hongjie, et al.
Publicado: (2020)

Patterns and Impact of Hypoglycemia, Hyperglycemia, and Glucose Variability on Inpatients with Insulin-Treated Cystic Fibrosis-Related Diabetes
por: Jones, Gregory C., et al.
Publicado: (2016)

Biomarkers of inflammation in infants with cystic fibrosis
por: Laguna, Theresa A., et al.
Publicado: (2018)

Practical Guidelines: Lung Transplantation in Patients with Cystic Fibrosis
por: Hirche, T. O., et al.
Publicado: (2014)

Erratum to “Practical Guidelines: Lung Transplantation in Patients with Cystic Fibrosis”
por: Hirche, T. O., et al.
Publicado: (2015)

Using social media to improve communication with people with cystic fibrosis
por: Dale, Christina, et al.
Publicado: (2016)

Health State Utility Data in Cystic Fibrosis: A Systematic Review
por: Mohindru, Bishal, et al.
Publicado: (2019)

US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis: executive summary
por: Floto, R Andres, et al.
Publicado: (2016)

Real-World Outcomes Among Patients with Cystic Fibrosis Treated with Ivacaftor: 2012–2016 Experience
por: Higgins, Mark, et al.
Publicado: (2020)

Reassessment of the importance of mucins in determining sputum properties in cystic fibrosis
por: Horsley, Alex, et al.
Publicado: (2014)

Optimising inhaled mannitol for cystic fibrosis in an adult population
por: Flume, Patrick A., et al.
Publicado: (2015)

Relationship between pulmonary exacerbations and daily physical activity in adults with cystic fibrosis
por: Savi, Daniela, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_j9blqqs3kddjon3avfqnia8evu